Motorized Fine Needle Biopsy vs Standard Needles

Launched by INSTITUTO ECUATORIANO DE ENFERMEDADES DIGESTIVAS · Mar 1, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new type of needle called the motorized fine needle biopsy (mFNB) to see how well it works compared to a standard needle for taking tissue samples from the pancreas and liver. The mFNB is designed to collect high-quality samples with less damage to the tissue, which could help doctors make more accurate diagnoses. The trial will involve two groups of patients: one will receive the standard needle and the other will use the new motorized needle. Researchers will focus on the quality of the samples and how accurately they can diagnose any potential diseases.

To participate in this trial, you need to be between 18 and 99 years old and referred for an endoscopic ultrasound (EUS)-guided biopsy of the liver or pancreas. You must also be able to give your consent to join the study. However, if you are pregnant, nursing, or have certain health conditions like blood clotting disorders, you won't be eligible to participate. If you take part, you can expect to have a biopsy procedure that aims to provide better quality tissue samples for testing. The trial is currently recruiting patients, and your involvement could help improve future diagnostic techniques for pancreas and liver diseases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients between 18 and 99 years
• • Patients referred to our center who require EUS-guided liver or pancreas biopsy.
• • Male or female patients.
• • Patients able to give consent
• Exclusion Criteria:
• • Pregnancy or nursing
• • Patients with coagulation disorders (platelets \<50.000/mm3, international normalised ratio (INR) \>2)
• • Any underlying medical condition that contraindicates EUS-guided fine needle biopsy such as anatomical alterations, significant gastric outlet obstruction, collateral intervening vessels.